Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research

Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

Please add ResearchGrants@BrightFocus.org to your institution’s white list to insure that the notification is not blocked by your organization’s SPAM filters.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research


Macular Degeneration Research
Completed Award

James Handa

Wilmer Eye Institute
Baltimore, MD

Title: Advanced Glycation Endproduct Mediated Cholesterol Deposition in Bruch's Membrane
Non-Technical Title:

Duration: April 1, 2005 - March 31, 2007
Award Type: Standard
Award Amount: $99,545


When looking at AMD eyes under the microscope, the most distinguishing change is basal deposits, or accumulations of material within Bruch’s membrane, a specialized scaffold upon which the retinal pigment epithelium (RPE) attaches. Prior to basal deposit formation, cholesterol (fat) is deposited into Bruch’s membrane. Dr. Handa believes that understanding how cholesterol gets deposited into Bruch’s membrane will help researchers to design targeted new treatments that prevent the onset of AMD or slow the inevitable progression from early to late disease.


Wu T, Tian J, Cutler RG, Telljohann RS, Bernlohr DA, Mattson MP, Handa JT. Knockdown of FABP5 mRNA decreases cellular cholesterol levels and results in decreased apoB100 secretion and triglyceride accumulation in ARPE-19 cells. Lab Invest. 2010 Jun;90(6):906-14. Epub 2009 May 11. PubMed Icon Google Scholar Icon